CompoAtlas

XCESS ULTRA CONCENTRATE (2019.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000202/2019
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
PRO, SIA
Manufacturer
ONSALESIT S.A.
Origin
Latvija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
4 kapsulas
Published pack size
kapsulas pa 700 mg
Published packaging
60 kapsulas

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
Selēnsminerals ; Selēns ; 82 ; μgSéléniumVitamin or mineral
Pienenes sakņu ekstraktsplants ; Pienenes sakņu ekstrakts ; Taraxacum officinale ; 300 ; mgNot recognisedRole not identified
Phytophare zaļās tējas lapu ekstraktsplants ; Phytophare zaļās tējas lapu ekstrakts ; Camellia sinensis ; 120 ; mgcamellia sinensisPlant
Kambodžas garcīnijas augļu ekstraktsplants ; Kambodžas garcīnijas augļu ekstrakts ; Garcinia cambogia ; 120 ; mgNot recognisedRole not identified
Ingvera saknes pulverisplants ; Ingvera saknes pulveris ; Zingiber officinale ; 40 ; mgzingiber officinalePlant
Kajennas piparu augļu ekstraktsplants ; Kajennas piparu augļu ekstrakts ; Capsicum annuum L. ; 20 ; mgcapsicum annuumPlant
Melno piparu augļu ekstraktsplants ; Melno piparu augļu ekstrakts ; Piper nigrum ; 10 ; mgpiper nigrumPlant
KofeīnsotherIngredients ; Kofeīns ; 400 ; mgNot recognisedRole not identified
L-tirozīnsotherIngredients ; L-tirozīns ; 300 ; mgNot recognisedRole not identified
MaltodekstrīnsotherIngredients ; MaltodekstrīnsNot recognisedRole not identified
ŽelatīnsotherIngredients ; ŽelatīnsNot recognisedRole not identified
Silīcija dioksīds (E551)otherIngredients ; Silīcija dioksīds (E551)Not recognisedRole not identified
Taukskābju magnija sāļi (E470b)otherIngredients ; Taukskābju magnija sāļi (E470b)Not recognisedRole not identified
Titāna dioksīds (E171)otherIngredients ; Titāna dioksīds (E171)Not recognisedRole not identified
Azorubīns (E122)otherIngredients ; Azorubīns (E122)Not recognisedRole not identified
Dzelzs oksīdi (E172) ( melnais)otherIngredients ; Dzelzs oksīdi (E172) ( melnais)Not recognisedRole not identified
Indigotīns (E132)otherIngredients ; Indigotīns (E132)Not recognisedRole not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Portugāle

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Ingvera saknes pulveris
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

  • Kajennas piparu augļu ekstrakts
    Read the warning, when it applies and the studies cited

    CAYENNE - CAPSICUM ANNUUM Oral

    Cautions and warnings

    Condition of application: All products.

    Keep out of the reach of children. If overdose or accidental ingestion occurs, call a poison control centre or get medical help right away (CPS 2008).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Bradley 2006; Boon and Smith 2004).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have stomach ulcers or inflammation (Brinker 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Digestion; Peripheral circulation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 27 March 2026

    CAYENNE - CAPSICUM ANNUUM/CAPSAICIN Topical

    Cautions and warnings

    Condition of application: All products.

    For external use only (US FDA 2023).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid contact with the eyes and mucous membranes. If contact occurs, rinse thoroughly with water (US FDA 2023).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist, worsen, or re-occur within a few days (US FDA 2023).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Keep out of the reach of children. If swallowed, call a poison control centre or get medical help right away (CPS 2008).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use if headache, redness, rashes, burning discomfort and/or hypersensitivity occur (Brayfield and Cadart 2024; Zhang et al. 2008; Hoffman 2003; APhA 2002; McCleane 2000).

    5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 27 March 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line